The objective of this proposal is to conduct a prospective randomized study comparing the utility of sedating patients undergoing transesophageal echocardiographic studies with a novel, recently-FDA-approved sedative agent, remimazolam, versus the sedative used in our current practice at UAB, propofol. This study will investigate whether remimazolam offers any benefit over current care vis-Ć -vis hemodynamics or efficiency/throughput. This study will be conducted at the University of Alabama at Birmingham. All outpatients and inpatients scheduled for elective/non-emergent TEE in the UAB Heart and Vascular Center TEE lab will be considered for enrollment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Blood pressure, physiologic parameter
Timeframe: Only blood pressures recorded on the anesthesia record during the anesthetic administered for the TEE procedure.
Heart rate, physiologic parameter
Timeframe: Only heart rate recorded on the anesthesia record during the anesthetic administered for the TEE procedure.